Pattern of Tau forms in CSF is altered in progressive supranuclear palsy

Neurobiology of Aging

Volumn 30, Issue 1, 2009, Pages 34-40

  Borroni, B ^a   Gardoni, F ^b   Parnetti, L ^c   Magno, L ^b   Malinverno, M ^b   Saggese, E ^c   Calabresi, P ^c   Spillantini, M G ^d   Padovani, A ^a   Di Luca, M ^b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cerebrospinal fluid; Corticobasal degeneration; Dementia with lewy bodies; Frontotemporal dementia; Parkinson disease; Progressive supranuclear palsy; Tau forms

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL EVALUATION; COGNITION; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE SEVERITY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DEGRADATION; TAUOPATHY;

AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 56049128135     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.05.009     Document Type: Article

References (21)

1. Arai T., Ikeda K., Akiyama H., Nonaka T., Hasegawa M., Ishiguro K., Iritani S., Tsuchiya K., Iseki E., Yagishita S., Oda T., and Mochizuki A. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann. Neurol. 55 (2004) 72-79
2. Arai T., Guo J.P., and McGeer P.L. Proteolysis of non-phosphorylated and phosphorylated tau by thrombin. J. Biol. Chem. 280 7 (2005) 5145-5153
3. Blennow K., and Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurol. 2 10 (2003) 605-613
4. Grossman M., Farmer J., Leight S., Work M., Moore P., Van Deerlin V., Pratico D., Clark C.M., Coslett H.B., Chatterjee A., Gee J., Trojanowski J.Q., and Lee V.M. Cerebrospinal fluid profile in Frontotemporal dementia and Alzheimer's disease. Ann. Neurol. 57 (2005) 721-729
5. Hodges J.R., Davies R.R., Xuereb J.H., Casey B., Broe M., Bak T.H., Kril J.J., and Halliday G.M. Clinicopathological correlates in frontotemporal dementia. Ann. Neurol. 56 (2004) 399-406
6. Johnson G., Seubert P., Cox T.M., Motter R., Brown J.P., and Galasko D. The Tau protein in human cerebrospinal fluid in Alzheimer's disease of proteolytically derived fragments. J. Neurochem. 68 (1997) 430-433
7. Kertesz A., McMonagle P., Blair M., Davidson W., and Munoz D.G. The evolution and pathology of frontotemporal dementia. Brain 128 Pt 9 (2005) 1996-2005
8. Lantos P.L. Diagnostic criteria for corticobasal degeneration. J. Neurol. Neurosurg. Psychiatry 69 5 (2000) 705-706
9. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Ann. Rev. Neurosci. 24 (2001) 1121-1159
10. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., Goetz C.G., Golbe L.I., Grafman J., Growdon J.H., Hallett M., Jankovic J., Quinn N.P., Tolosa E., and Zee D.S. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47 1 (1996) 1-9
11. Movement Disorders Society Scientific Issues Committee. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov. Disord. 18 (2003) 467-486
12. Work Group on Frontotemporal Dementia Pick's Disease. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch. Neurol. 58 11 (2001) 1803-1809
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
14. McKeith I.G., Ballard C.G., Perry R.H., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., and Yamada M. Consortium on DLB. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 54 (2000) 1050-1058
15. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., and Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51 6 (1998) 1546-1554
16. Pijnenburg Y.A., Schoonenboom N.S., Rosso S.M., Mulder C., Van Kamp G.J., Van Swieten J.C., and Scheltens P. CSF tau and Abeta42 are not useful in the diagnosis of frontotemporal lobar degeneration. Neurology 62 9 (2004) 1649
17. Riemenschneider M., Wagenpfeil S., Diehl J., Lautenschlager N., Theml T., Heldmann B., Drzezga A., Jahn T., Forstl H., and Kurz A. Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology 58 11 (2002) 1622-1628
18. Spillantini M.G., and Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 21 (1998) 428-433
19. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in lewy bodies. Nature 388 6645 (1997) 839-840
20. Urakami K., Wada K., Arai H., Sasaki H., Kanai M., Shoji M., Ishizu H., Kashihara K., Yamamoto M., Tsuchiya-Ikemoto K., Morimatsu M., Takashima H., Nakagawa M., Kurokawa K., Maruyama H., Kaseda Y., Nakamura S., Hasegawa K., Oono H., Hikasa C., Ikeda K., Yamagata K., Wakutani Y., Takeshima T., and Nakashima K. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J. Neurol. Sci. 183 (2001) 95-98
21. Vandermeeren M., Mercken M., Vanmechelen E., Six J., van de Voorde A., Martin J.J., and Cras P. Detection of Tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61 (1993) 1828-1834